Correspondence 0001493152-23-003663 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Feb. 6, 2023 · CIK: 0001106838 · Accession: 0001493152-23-003663
AI Filing Summary & Sentiment
File numbers found in text: 333-269307
Show Raw Text
CORRESP
1
filename1.htm
February
6, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Sonnet BioTherapeutics Holdings,
Inc. (the “Company”)
Registration Statement on
Form S-1 (File No. 333-269307)
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration
Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 5:00 p.m.,
Eastern Time, on February 7, 2023, or as soon as practicable thereafter.
Please
call Alexander E. Dinur of Lowenstein Sandler LLP at 973-422-6732 to confirm the effectiveness of the Registration Statement or with
any questions.
Very truly yours,
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.
By:
/s/
Pankaj Mohan
Name:
Pankaj
Mohan
Title:
Chief
Executive Officer